Therefore, patients classified as lumA that display gene expression levels more akin to lumB tumours and also have high CNA burden may benefit from the more aggressive treatment regime used for lumB patients in contrast to standard endocrine therapy for lumA patients [36]. Here, TMEM43 is linked to neoplasm.